Erythema Marginatum
Erythema marginatum (EM) is a distinctive rash that is best known as an important clinical sign of acute rheumatic fever. It is one of the major Jones criteria that doctors use to diagnose this post-streptococcal condition affecting the heart, joints and nervous system.
At Haute-Derma, we take erythema marginatum very seriously. Recognizing its characteristic ring- and arc-shaped pattern allows us to start antibiotics promptly and stop the disease from progressing to serious damage to the joints, heart and central nervous system.
Our Approach to Erythema Marginatum
Our doctors focus on spotting the fleeting but specific features of erythema marginatum:
- Appearance: Pink-red rings with a bright edge and a paler center, forming circles or linked, polycyclic arcs.
- Typical location: Usually the trunk and upper limbs and thighs; it almost never affects the face.
- Distinctive behavior: The rash is neither itchy nor painful, and it tends to spread quickly at the edges while the center fades.
Because EM can appear and disappear within hours or days, prompt examination and photographs of the rash are essential.
How We Diagnose It at Haute-Derma
Haute-Derma uses a systematic screening process to connect what we see on the skin with any underlying internal disease:
- Clinical recognition: We look for smooth-edged, non-scaly bands of redness that may become more obvious with heat (for example, after a warm bath).
- Infection history: We ask about a sore throat or fever in the 2–4 weeks before the rash appeared.
- Laboratory tests (with other specialties):
- Blood tests: Antistreptolysin O (ASO) antibodies, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP).
- Throat culture: To detect group A streptococcus.
- Screening for complications: If acute rheumatic fever is suspected, we arrange an electrocardiogram (ECG) or echocardiogram to look for hidden heart valve damage.
How Erythema Marginatum Is Treated at Haute-Derma
Because EM results from a systemic immune reaction, treatment at Haute-Derma targets the underlying cause:
- Treating the causative infection: Antibiotics (usually a penicillin) given according to standard guidelines to eradicate any remaining streptococci.
- Controlling inflammation: Nonsteroidal anti-inflammatory drugs (NSAIDs) or salicylates to calm systemic inflammation and help prevent joint and heart complications.
- Skin care: Since EM rarely itches or causes discomfort, topical treatment is usually unnecessary. Instead, we track how the rash evolves as a guide to the response to systemic treatment.
- Long-term follow-up: Regular follow-up visits to monitor heart health and make sure no lasting effects of rheumatic fever develop.
